Transport
Marlette Regional Hospital
Marlette Regional Hospital was paid $7.45M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoMARLETTE REGIONAL HOSPITAL
MARLETTE, MI 48453
MARLETTE, MI 48453
33aNPI1346325214assigned 10/26/2006
33bProvider typeAmbulance
28Total paid$7.45M
24GClaims183,271
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulance providers in Michigan
Rank by total paid#6 of 84
Median peer was paid$399K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,763 | $610K | |
| 2019 | 23,028 | $680K | |
| 2020 | 21,122 | $775K | |
| 2021 | 29,583 | $1.16M | |
| 2022 | 33,015 | $1.45M | |
| 2023 | 33,957 | $1.49M | |
| 2024incomplete | 24,803 | $1.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 10,772 | 10,154 | $1.63M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 6,449 | 6,007 | $1.48M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 3,044 | 2,838 | $1.08M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.2% | 3,604 | 3,362 | $391K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 4.8% | 1,458 | 1,284 | $359K |
| A0425 | Ground mileage, per statute mile | 4.7% | 2,233 | 1,841 | $351K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.4% | 1,257 | 1,227 | $256K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 2,642 | 2,545 | $240K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.8% | 1,972 | 1,417 | $208K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.4% | 1,667 | 1,630 | $182K |
| 71046 | Radiologic examination, chest; 2 views | 2.2% | 3,555 | 3,441 | $163K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.0% | 3,630 | 3,152 | $148K |
104 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 3,835 | $140K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,342 | $71K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,171 | $70K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,141 | $68K |
| 80061 | Lipid panel | <1% | 4,692 | $65K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 664 | $64K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,924 | $52K |
| 80053 | Comprehensive metabolic panel | <1% | 12,438 | $44K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 181 | $42K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,303 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,989 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,356 | $32K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,503 | $26K |
| 71045 | Radiologic examination, chest; single view | <1% | 490 | $24K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 222 | $23K |
| G0378 | Hospital observation service, per hour | <1% | 97 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,170 | $18K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 919 | $15K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 100 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,513 | $13K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 107 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,368 | $10K |
| 84439 | <1% | 1,599 | $7K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,280 | $6K |
| 73630 | <1% | 412 | $5K | |
| 73130 | <1% | 486 | $5K | |
| 82607 | <1% | 524 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 54 | $4K |
| 83735 | <1% | 3,093 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 40 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,386 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,291 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,103 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,148 | $2K |
| 97162 | <1% | 26 | $2K | |
| 73610 | <1% | 243 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $2K |
| 73030 | <1% | 105 | $2K | |
| 82043 | <1% | 476 | $2K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 13 | $1K |
| 85610 | <1% | 2,479 | $1K | |
| 83880 | <1% | 565 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 81 | $920.40 |
| 83690 | <1% | 2,857 | $816.44 | |
| 93971 | <1% | 12 | $805.90 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 797 | $792.00 |
| 83540 | <1% | 242 | $783.16 | |
| 87186 | <1% | 338 | $751.42 | |
| 82728 | <1% | 110 | $740.72 | |
| 73110 | <1% | 42 | $733.77 | |
| 81001 | <1% | 3,738 | $671.96 | |
| 84702 | <1% | 88 | $619.74 | |
| 87070 | <1% | 551 | $611.53 | |
| 73562 | <1% | 14 | $575.10 | |
| 73564 | <1% | 12 | $472.76 | |
| 0012A | <1% | 13 | $458.69 | |
| 0011A | <1% | 14 | $376.60 | |
| 85730 | <1% | 1,587 | $369.47 | |
| 84484 | <1% | 2,375 | $330.60 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 109 | $320.83 |
| 87088 | <1% | 217 | $320.33 | |
| 81003 | <1% | 1,871 | $300.26 | |
| 85379 | <1% | 527 | $292.66 | |
| 81025 | <1% | 2,020 | $234.02 | |
| 85652 | <1% | 195 | $222.70 | |
| G0008 | Administration of influenza virus vaccine | <1% | 30 | $189.00 |
| 83550 | <1% | 41 | $169.14 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,573 | $154.86 |
| 80305 | <1% | 448 | $132.53 | |
| 84703 | <1% | 448 | $114.82 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $78.94 |
| A9270 | Non-covered item or service | <1% | 10,149 | $76.55 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 110 | $73.09 |
| 82150 | <1% | 151 | $53.69 | |
| 83605 | <1% | 1,415 | $42.18 | |
| 86140 | <1% | 14 | $33.95 | |
| 84460 | <1% | 185 | $33.27 | |
| 84450 | <1% | 185 | $32.49 | |
| 86308 | <1% | 12 | $18.08 | |
| 87807 | <1% | 59 | $17.26 | |
| 80143 | <1% | 12 | $15.43 | |
| 84100 | <1% | 18 | $14.28 | |
| 90715 | <1% | 13 | $12.73 | |
| 82247 | <1% | 15 | $11.01 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,423 | $7.82 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,813 | $5.96 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,315 | $5.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 407 | $4.22 |
| 82550 | <1% | 13 | $4.09 | |
| 82248 | <1% | 12 | $3.83 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 96 | $0.00 |
| 96376 | 0% | 737 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 57 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 12 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 178 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 12 | $0.00 |
| 87040 | 0% | 29 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 13 | $0.00 |
| 82962 | 0% | 15 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 16 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,427 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 665 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 119 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCONNACHIE, ANGELA (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Marlette Regional Hospital | Port Sanilac, MI | $398K |
| Marlette Regional Hospital | Marlette, MI | $74K |
| Marlette Regional Hospital | Marlette, MI | $70K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.